However, we acknowledge that the number of patients with stage II colon cancer and low CDX2 expression who had adjuvant chemotherapy in our study was small (fewer than 10 patients), compared to the study by Dalerba et al., where there were 25 patients. The gene discussed is CDX2; the disease is colonic neoplasm.